In this fifth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC ...
In this fourth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC ...
An analysis estimates Trump increased his stock holdings from $1.7 million in 2024 to up to $56.2 million last year.
Key Points of FY2025 Dispensing Medical Expenses and Pharmaceutical ExpensesBased on the 'FY2025 Trends in Medical Expenses: ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "Active Pharmaceutical Ingredients Market Report by Drug Type, Synthesis, Type of Manufacturer, Application, Country and Company Analysis 2026-2034" has been added to ...
GNI Group's current stock price trend and supply-demand balance The 'potential for upside' as seen from margin trading ...
1don MSN
Analysis - Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
By Sriparna Roy and Bhanvi Satija Oct 15 (Reuters) - Revolution Medicines is laying the groundwork for a broad European ...
Page 5th Edition Tracks 46 Recent CDx Approvals and Partnerships, With AI Impact Analysis and Forecasts by Application, Technology, Funding Source and CountryDublin, Oct. (GLOBE NEWSWIRE) -- ...
In today’s Pharmaceutical Executive Daily, Gilead and Vir Biotechnology enter a collaboration worth up to $1.87 billion to ...
BioSpectrum India on MSN
Indian pharma market records 13.5% value growth, volume growth rises to 3% in September 2026
September 2026 performance marks a notable improvement in volume growth ...
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating ...
Experts warn prediction markets are exposing gaps in pharma vendor confidentiality agreements, Roche licenses Rona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results